BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based Chemotherapy

Update Il y a 4 ans
Reference: NCT01672671

Woman Man

Extract

The purpose of this study is to assess efficacy of platinum-based neoadjuvant chemotherapy in correlation with BRCA1-associated DNA repair dysfunction in patients with early triple negative breast cancer.


Inclusion criteria

  • Early Triple Negative Breast Cancer

Links